Statin use and lipid levels in older adults: National Health and Nutrition Examination Survey, 2001 to 2006

Journal of Clinical Lipidology

Volumn 4, Issue 6, 2010, Pages 483-490

  Robinson, Jennifer G ^a   Booth, Benjamin ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Cardiovascular disease; Elderly; Lipids; Population; Prevention; Statins

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; ELDERLY CARE; ETHNICITY; FEMALE; HEALTH SURVEY; HEART INFARCTION; HISPANIC; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PHYSICAL EXAMINATION; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RACE; SECONDARY PREVENTION; SELF REPORT; STROKE;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOLIPIDEMIC AGENTS; MALE; NUTRITION SURVEYS; ODDS RATIO; RISK FACTORS; SEX FACTORS;

EID: 78649647291     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2010.10.002     Document Type: Article

References (11)

1. D. Lloyd-Jones, R.J. Adams, T.M. Brown American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics - 2010 update. A report from the American Heart Association Circulation 121 2010 e46 e215
2. S. Setoguchi, R.J. Glynn, J. Avorn, R. Levin, and W.C. Winkelmayer Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons ≥65 years of age Am J Cardiol 100 2007 1061 1067
3. E.S. Ford, U.A. Ajani, and J.B. Croft Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 N Engl J Med 356 2007 2388 2398
4. Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
5. J.G. Robinson, G. Bakris, J. Torner, N.J. Stone, and R. Wallace Is it time for a cardiovascular primary prevention trial in the elderly? Stroke 38 2007 441 450
6. P.M. Ridker, E. Danielson, F.A. Fonseca JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
7. D. Mann, K. Reynolds, D. Smith, and P. Muntner Trends in statin use and low-density lipoprotein cholesterol levels among US adults: Impact of the 2001 National Cholesterol Education Program Guidelines Ann Pharmacother 42 2008 1208 1215
8. H. Ghandehari, S. Kamal-Bahl, and N.D. Wong Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: The National Health and Nutrition Examination Survey 2003-2004 Am Heart J 156 2008 112 119
9. National Cholesterol Education Panel Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report Circulation 106 2002 3143 3421
10. S.M. Grundy, J.I. Cleeman, C.N. Merz National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239 (Pubitemid 38924592)
11. M.W. Cavanaugh-Hussey, J.D. Berry, and D.M. Lloyd-Jones Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool Prev Med 47 2008 619 623